35.57 1.15 (3.34%) | 02-14 16:00 | |||||||||||||
|
|
Short term | ![]() |
|||
Mid term | ![]() ![]() ![]() |
|||
Targets | 6-month : | 50.9 | 1-year : | 71.32 |
Resists | First : | 43.58 | Second : | 61.06 |
Pivot price | 39.22 ![]() |
|||
Supports | First : | 15.3 | Second : | 12.72 |
MAs | MA(5) : | 33.61 ![]() |
MA(20) : | 40.09 ![]() |
MA(100) : | 41.24 ![]() |
MA(250) : | 26.31 ![]() |
|
MACD | MACD : | -2.6 ![]() |
Signal : | -1.7 ![]() |
%K %D | K(14,3) : | 40.5 ![]() |
D(3) : | 38.8 ![]() |
RSI | RSI(14): 44.5 ![]() |
|||
52-week | High : | 61.06 | Low : | 1.39 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ TECX ] has closed above bottom band by 40.3%. Bollinger Bands are 146.5% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 14 days. This is a sign that the current trend might continue.
If tomorrow: | Open lower | Open higher |
High: | 36.02 - 36.19 | 36.19 - 36.35 |
Low: | 33.68 - 33.87 | 33.87 - 34.05 |
Close: | 35.24 - 35.57 | 35.57 - 35.87 |
Sat, 15 Feb 2025
Tectonic Therapeutic (NASDAQ:TECX) Sees Significant Growth in Short Interest - MarketBeat
Fri, 14 Feb 2025
Tectonic jumps on positive data from early-stage trial for lead asset - MSN
Thu, 13 Feb 2025
Tectonic Therapeutic (NASDAQ:TECX) Shares Gap Up Following Insider Buying Activity - MarketBeat
Fri, 07 Feb 2025
Tectonic Therapeutic director Timothy Springer buys $39.9 million in stock - MSN
Mon, 03 Feb 2025
Major Funding Alert: Tectonic Therapeutic Lands $185M from Elite Investors at Premium Price - StockTitan
Mon, 03 Feb 2025
Tectonic Announces $185 Million Private Placement - GlobeNewswire
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
Exchange:
NASDAQ
|
|
Sector:
|
|
Industry:
|
|
Shares Out | 15 (M) |
Shares Float | 6 (M) |
Held by Insiders | 41.6 (%) |
Held by Institutions | 49.1 (%) |
Shares Short | 571 (K) |
Shares Short P.Month | 512 (K) |
EPS | -3.07 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 11.28 |
Profit Margin | 0 % |
Operating Margin | 0 % |
Return on Assets (ttm) | 0 % |
Return on Equity (ttm) | 0 % |
Qtrly Rev. Growth | 0 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | 0 |
EBITDA (p.s.) | -3.53 |
Qtrly Earnings Growth | 0 % |
Operating Cash Flow | 0 (M) |
Levered Free Cash Flow | 0 (M) |
PE Ratio | -11.59 |
PEG Ratio | 0 |
Price to Book value | 3.15 |
Price to Sales | 0 |
Price to Cash Flow | 0 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |